Assessment of Anti-Carcinogenic Potential of Neem (Azadirachta indica) Leaf Extract Loaded Calcium Phosphate Nanoparticles against Experimentally Induced Mammary Carcinogenesis in Rats

Jump To References Section

Authors

  • Department of Veterinary Pathology, Madras Veterinary College, Tamil Nadu Veterinary and Animal Sciences University, Chennai - 600 007, Tamil Nadu ,IN
  • Department of Veterinary Pathology, Madras Veterinary College, Tamil Nadu Veterinary and Animal Sciences University, Chennai - 600 007, Tamil Nadu ,IN
  • Department of Veterinary Pathology, Madras Veterinary College, Tamil Nadu Veterinary and Animal Sciences University, Chennai - 600 007, Tamil Nadu ,IN
  • Department of Veterinary Pathology, Madras Veterinary College, Tamil Nadu Veterinary and Animal Sciences University, Chennai - 600 007, Tamil Nadu ,IN
  • Department of Veterinary Pathology, Madras Veterinary College, Tamil Nadu Veterinary and Animal Sciences University, Chennai - 600 007, Tamil Nadu ,IN

DOI:

https://doi.org/10.18311/ti/2023/v30i4/35228

Keywords:

Calcium Phosphate Nanoparticles, DMBA, Mammary Tumor, Neem Leaf Extract, Rats

Abstract

Considering the need for alternative medicine in alleviation of tumors and use of nanotechnology in furthering the action of herbal/natural products, the present study was designed to evaluate the anti-carcinogenic potential of Neem leaf Extract (NE) loaded calcium phosphate nanoparticles (NE-CaNP) on 7, 12-Dimethylbenzanthracene (DMBA) induced mammary tumors in female Sprague-Dawley rats. Ultrastructurally, the NE-CaNP were smooth, spherical with a tendency to agglomerate and evenly distributed. The NE-CaNP had a mean diameter of 231.4 ± 89.2 nm and zeta potential of -31.3mV. The mean coupling efficiency of CaNP was 90-91 %. The experimental trial consisted of control, NE-CaNP control, DMBA, DMBA+NE and DMBA+NE-CaNP groups. The mean latency periods for occurrence of mammary tumor were significantly (P ≤ 0.05) increased in the DMBA+NE and DMBA+NE-CaNP groups compared to the DMBA group. The mean latency period in the DMBA+NE-CaNP group was significantly (P ≤ 0.05) higher than the DMBA+NE group. The mean tumor frequency, volume and weight were significantly (P ≤ 0.05) decreased in the DMBA+NE-CaNP group. Histopathologically, the number of benign lesions was found highest (47.54%) in DMBA+NE-CaNP group rats. The relative percent reduction in malignancy as compared to the DMBA group was 42.86% and 54.29% in the DMBA+NE and DMBA+NE-CaNP groups respectively. In conclusion, the neem leaf extract loaded calcium phosphate nanoparticles were found to have better anti-carcinogenic potential by significantly reducing the incidence, frequency, weight, volume, malignancy and increased the tumor latency period of DMBA induced mammary tumors in female Sprague-Dawley rats as compared to rats treated with neem extract alone. Findings of the present study suggested that the neem leaf extract loaded calcium phosphate nanoparticles (NE-CaNP) has immense anticancer potential in terms of reduction in tumor burden and malignancy.

Downloads

Download data is not yet available.

Published

2023-12-11

How to Cite

Chavhan, S. G., Balachandran, C., Nambi, A. P., Raj, G. D., & Vairamuthu, S. (2023). Assessment of Anti-Carcinogenic Potential of Neem (<i>Azadirachta indica</i>) Leaf Extract Loaded Calcium Phosphate Nanoparticles against Experimentally Induced Mammary Carcinogenesis in Rats. Toxicology International, 30(4), 659–674. https://doi.org/10.18311/ti/2023/v30i4/35228
Received 2023-09-29
Accepted 2023-11-09
Published 2023-12-11

 

References

Jabir NR, Tabrez S, Ashraf GM, Shakil S, Damanhouri GA, Kamal MA. Nanotechnology-based approaches in anticancer research. Int J Nanomedicine. 2012; 7:4391-08. https://doi.org/10.2147/IJN.S33838 DOI: https://doi.org/10.2147/IJN.S33838

Desai AG, Qazi GN, Ganju RK, El-Tamer M, Singh J, Saxena AK. Medicinal plants and cancer chemoprevention. Curr Drug Metab. 2008; 9:581-91. https://doi. org/10.2174/138920008785821657 DOI: https://doi.org/10.2174/138920008785821657

Bose A, Chakraborty K, Sarkar K, Goswami S, Chakraborty T, Pal S. Neem leaf glycoprotein induces perforin-mediated tumor cell killing by T and NK cells through differential regulation of IFN-gamma signaling. J Immunother. 2009; 32:42-53. https://doi.org/10.1097/CJI.0b013e31818e997d DOI: https://doi.org/10.1097/CJI.0b013e31818e997d

Sarkar K, Bose A, Haque E, Chakraborty K, Chakraborty T, Goswami S. Induction of type 1 cytokines during neem leaf glycoprotein assisted carcinoembryonic antigen vaccination is associated with nitric oxide production. Int Immunopharmacol. 2009; 9:753-60. https://doi. org/10.1016/j.intimp.2009.02.016 DOI: https://doi.org/10.1016/j.intimp.2009.02.016

Haque E, Mandal I, Pal S, Baral R. Prophylactic dose of neem (Azadirachta indica) leaf preparation restricting murine tumor growth is non-toxic, hematostimulatory and immunostimulatory. Immunopharmacol Immunotoxicol. 2006; 28:33-50. https://doi.org/10.1080/08923970600623632 DOI: https://doi.org/10.1080/08923970600623632

Chakraborty K, Bose A, Pal S, Sarkar K, Goswami S, Ghosh D. Neem leaf glycoprotein restores the impaired chemotactic activity of peripheral blood mononuclear cells from head and neck squamous cell carcinoma patients by maintaining CXCR3/ CXCL10 balance. Int Immunopharmacol. 2008; 8:330-40. https://doi.org/10.1016/j.intimp.2007.10.015 DOI: https://doi.org/10.1016/j.intimp.2007.10.015

Bose A, Chakraborty K, Sarkar K, Goswami S, Haque E, Chakraborty T. Neem leaf glycoprotein directs T-betassociated type 1 immune commitment. Hum Immunol. 2009; 70:6-15. https://doi.org/10.1016/j.humimm.2008.09.004 DOI: https://doi.org/10.1016/j.humimm.2008.09.004

Priyadarsini RV, Manikandan P, Kumar GH, Nagini S. The neem limonoids azadirachtin and nimbolide inhibit hamster cheek pouch carcinogenesis by modulating xenobioticmetabolizing enzymes, DNA damage, antioxidants, invasion and angiogenesis. Free Radic Res. 2009; 43:492-04. https://doi.org/10.1080/10715760902870637 DOI: https://doi.org/10.1080/10715760902870637

Gelperina S, Kisich K, Iseman MD, Heifets L. The potential advantages of nanoparticle drug delivery systems in chemotherapy of tuberculosis. Am J Respir Crit Care Med. 2005; 172:1487-90. https://doi.org/10.1164/rccm.200504- 613PP DOI: https://doi.org/10.1164/rccm.200504-613PP

Cho K, Wang X, Nie S, Chen ZG, Shin DM. Therapeutic nanoparticles for drug delivery in cancer. Clin Cancer Res. 2008; 14:1310-16. https://doi.org/10.1158/1078-0432.CCR- 07-1441 DOI: https://doi.org/10.1158/1078-0432.CCR-07-1441

Ranganathan R, Madanmohan S, Kesavan A. Nanomedicine: Towards development of patient-friendly drug-delivery systems for oncological applications. Int J Nanomedicine. 2012; 7:1043-60. https://doi.org/10.2147/IJN.S25182 DOI: https://doi.org/10.2147/IJN.S25182

Epple M, Kovtun A. Functionalized calcium phosphate nanoparticles for biomedical application. Key Eng Mater. 2010; 441:299-05. https://doi.org/10.4028/www.scientific. net/KEM.441.299 DOI: https://doi.org/10.4028/www.scientific.net/KEM.441.299

He Q, Mitchell AR, Johnson SL, Wagner-Bartak C, Morcol T, Bell JD. Calcium Phosphate Nanoparticle Adjuvant. Clin Diagn Lab Immunol. 2000; 7:899-03. https://doi. org/10.1128/CDLI.7.6.899-903.2000 DOI: https://doi.org/10.1128/CDLI.7.6.899-903.2000

Carlsson G, Gullberg B, Hafstrom L. Estimation of liver tumor volume using different formulas - An experimental study in rats. J Cancer Res Clin. 1983; 105:20-23. https:// doi.org/10.1007/BF00391826 DOI: https://doi.org/10.1007/BF00391826

Mann PC, Boorman GA, Lollini LO, McMartin DN, Goodman DG. Proliferative lesions of the mammary gland in rats, IS-2. In: Guides for Toxicologic Pathology. STP/ ARP/AFIP Publishers, Washington DC, USA. 1996; 1-7.

Russo J, Russo IH. Atlas and histologic classification of tumors of the rat mammary gland. J Mammary Gland Biol Neoplasia. 2000; 5:187-200. https://doi. org/10.1023/A:1026443305758 DOI: https://doi.org/10.1023/A:1026443305758

Costa I, Solanas M, Escrich E. Histopathologic characterization of mammary neoplastic lesions induced with 7, 12-dimethylbenz (a) anthracene in the rat. Arch Pathol Lab Med. 2002; 126:915-27. https://doi. org/10.5858/2002-126-0915-HCOMNL DOI: https://doi.org/10.5858/2002-126-0915-HCOMNL

Wang P, Li C, Gong H, Jiang X, Wang H, Li K. Effects of synthesis conditions on the morphology of CaP nanoparticles produced by wet chemical process. Powder Technol. 2010; 203:315-21. https://doi.org/10.1016/j.powtec.2010.05.023 DOI: https://doi.org/10.1016/j.powtec.2010.05.023

Behera T, Swain P. Antigen adsorbed calcium phosphate nanoparticles stimulate both innate and adaptive immune response in fish (Labeo rohita). Cell Immunol. 2011; 271:350-59. https://doi.org/10.1016/j.cellimm.2011.07.015 DOI: https://doi.org/10.1016/j.cellimm.2011.07.015

Koppad S, Dhinakar Raj G, Gopinath VP, John Kirubaharan J, Thangavelu A, Thiagarajan V. Calcium phosphate coupled Newcastle disease vaccine elicits humoral and cell mediated immune responses in chickens. Res Vet Sci. 2011; 91:384- 90. https://doi.org/10.1016/j.rvsc.2010.09.008 DOI: https://doi.org/10.1016/j.rvsc.2010.09.008

Chen R, Qian Y, Li R, Zhang Q, Liu D, Wang M, Xu Q. Methazolamide calcium phosphate nanoparticles in an ocular delivery system. Yakugaku Zasshi. 2010; 130:419-24. https://doi.org/10.1248/yakushi.130.419 DOI: https://doi.org/10.1248/yakushi.130.419

Nimal TR. Development of extracellular matrix-nano hydroxyapatite composite scaffold for based bone tissue engineering. MTech thesis submitted to National Institute of Technology, Rourkela, India; 2013.

Mercado DF, Giuliana M, Malandrino M, Rubert AA, Montoneri E, Celi L, Prevot AB, Gonzalez MC. Paramagnetic iron-doped hydroxyapatite nanoparticles with improved metal sorption properties-A bio-organic substrates-mediated synthesis. ACS Appl Mater Interfaces. 2014; 6:3937-46. https://doi.org/10.1021/am405217j DOI: https://doi.org/10.1021/am405217j

Bhattacharyya KG, Sharma A. Adsorption of Pb (II) from aqueous solution by Azadirachta indica (neem) leaf powder. J Hazard Mater. 2004; 113:97-109. https://doi.org/10.1016/j. jhazmat.2004.05.034 DOI: https://doi.org/10.1016/j.jhazmat.2004.05.034

Giganti DM, Niehans GA, Reichert MA, Bliss RL. Post-initiation treatment of rats with indole-3-carbinol or b-naphthoflavone does not suppress 7, 12-dimethylbenz[a] anthracene induced mammary gland carcinogenesis. Cancer Lett. 2000; 160:209- 18. https://doi.org/10.1016/S0304-3835(00)00594-2 DOI: https://doi.org/10.1016/S0304-3835(00)00594-2

Russo IH, Russo J. Mammary gland neoplasia in long-term rodent studies. Environ Health Perspect. 1996; 104:938-67. https://doi.org/10.1289/ehp.96104938 DOI: https://doi.org/10.1289/ehp.96104938

Vinothini G, Manikandan P, Anandan R, Nagini S. Chemoprevention of rat mammary carcinogenesis by Azadirachta indica leaf fractions: Modulation of hormone status, xenobiotic-metabolizing enzymes, oxidative stress, cell proliferation and apoptosis. Food Chem Toxicol. 2009; 47:1852-63. https://doi.org/10.1016/j.fct.2009.04.045 DOI: https://doi.org/10.1016/j.fct.2009.04.045

Tepsuwan A, Kupradinun P, Kusamran WR. Chemopreventive potential of neem flowers on carcinogeninduced rat mammary and liver carcinogenesis. Asian Pacific J Cancer Prev. 2002; 3:231-38.

Ahlersova E, Ahlers I, Kubatka P, Bojkova B, Mocikova K, Gajdosova S, Onderkova HM. Melatonin and retinyl acetate as chemo preventives in DMBA-induced mammary carcinogenesis in female Sprague-Dawley rats. Folia Biol. 2000; 46:69-72.

Jalantha P. Pathological evaluation of anti-tumor effect of curcumin against experimentally induced mammary tumor in rats [MSc Thesis]. Chennai, India: Tamil Nadu Veterinary and Animal Sciences University; 2012.

Sachdev GP, Wen G, Martin B, Kishore GS, Fox OF. γ-glutamyl-transpeptidase in chemically induced rat mammary gland carcinogenesis in specific dietary states. Proc Okla Acad Sci. 1980; 60:1-4.

Conti P, Castellani ML, Durasamy K, Vincenzo S, Jacopo V, Stefano T, Filiberto M, Alessandro P, Lutiis MAD, Tagen M, Theoharides TC. Role of mast cells in tumor growth. Ann Clin Lab Sci. 2007; 37:315-22.

Jana S, Ghosh S, De A, Pal S, Sengupta S, Ghosh T. Quantitative analysis and comparison of mast cells in breast carcinomas and axillary lymph nodes. Clin Cancer Invest J. 2017; 6:214-18. https://doi.org/10.4103/ccij.ccij_52_17 DOI: https://doi.org/10.4103/ccij.ccij_52_17